# TRXB (Trex Bio, Inc.) - SEC EDGAR Financial Statements

> Trex Bio, Inc. reported $88.75M in total assets through September 30, 2026 from SEC EDGAR filings.

- Canonical: https://convexityos.com/fundamentals/TRXB
- Markdown: https://convexityos.com/fundamentals/TRXB.md
- SEC CIK: 0002139097
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:48 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0002139097&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2026 | -- | Sep 30, 2026 |
| Operating Income | FY 2026 | -- | Operating profit |
| Net Income | FY 2026 | -- | GAAP bottom line |
| Diluted EPS | FY 2026 | -- | Split-adjusted |
| Free Cash Flow | FY 2026 | -- | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | $78.15M | Total debt: $2.81M |

## Income Statement

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Sep 2025 | Jun 2025 | Mar 2025 |
| --- | --- | --- | --- | --- | --- | --- |
| Research & Development | $11.43M | -- | -- | $6.97M | -- | -- |
| Total Operating Expenses | $13.92M | -- | -- | $8.71M | -- | -- |
| **Operating Income** | -$13.92M | -- | -- | -$8.71M | -- | -- |
| Interest Income | $768K | -- | -- | $853K | -- | -- |
| Income Before Tax | -$13.15M | -- | -- | -$7.86M | -- | -- |
| Income Tax Expense | $88K | -- | -- | $0 | -- | -- |
| **Net Income** | -$13.24M | -$13.09M | -$16.22M | -$7.86M | -$8.33M | -$9.39M |
| Basic EPS | -$10.06 | -- | -- | -$7.58 | -- | -- |
| **Diluted EPS** | -$10.06 | -- | -- | -$7.58 | -- | -- |
| Basic Shares Outstanding | 1.3M | -- | -- | 1.0M | -- | -- |
| Diluted Shares Outstanding | 1.3M | -- | -- | 1.0M | -- | -- |

## Balance Sheet

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Dec 2025 |
| --- | --- | --- |
| Cash & Cash Equivalents | $16.81M | $15.19M |
| Short-Term Investments | $61.34M | $52.53M |
| **Cash & Short-Term Investments** | $78.20M | $67.72M |
| **Total Current Assets** | $79.85M | $71.43M |
| Property, Plant & Equipment, Net | $826K | $482K |
| Other Non-Current Assets | $5.35M | $538K |
| **Total Non-Current Assets** | $8.91M | $1.70M |
| **Total Assets** | $88.75M | $73.13M |
| Accounts Payable | $1.72M | $371K |
| **Total Current Liabilities** | $10.53M | $4.99M |
| Other Non-Current Liabilities | $103K | $72K |
| **Total Non-Current Liabilities** | $3.50M | $1.24M |
| **Total Liabilities** | $14.03M | $6.24M |
| **Total Debt (incl. Leases)** | $2.81M | $717K |
| Common Stock | $0 | $0 |
| Retained Earnings | -$136.8M | -$94.26M |
| Accumulated Other Comp. Income | -$151K | $17K |
| **Total Stockholders' Equity** | -$134.1M | -$92.12M |
| Total Equity | -$134.1M | -$92.12M |

## Cash Flow Statement

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Sep 2025 | Jun 2025 | Mar 2025 |
| --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$13.24M | -$13.09M | -$16.22M | -$7.86M | -$8.33M | -$9.39M |
| Stock-Based Compensation | $178K | -- | -- | $129K | -- | -- |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Sep 2025 | Jun 2025 | Mar 2025 |
| --- | --- | --- | --- | --- | --- | --- |
| Current Ratio | 7.58x | -- | -- | -- | -- | -- |
| Quick Ratio | 7.43x | -- | -- | -- | -- | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
